Based on the World Health Organization Medical Eligibility Criteria (WHO MEC), which contraceptive method is most appropriate for each patient's clinical presentation?
- A 30-year-old woman on apixaban for an unprovoked pulmonary embolism who experiences heavy, prolonged menses.Levonorgestrel-releasing intrauterine device
- A 25-year-old woman diagnosed with active, purulent cervicitis today who requests immediate initiation of a highly effective, long-acting method.Etonogestrel subdermal implant
- A 37-year-old woman who smokes one pack of cigarettes daily and prefers a daily, patient-controlled oral contraceptive.Progestin-only oral pill
- A 41-year-old woman currently undergoing chemotherapy for estrogen-receptor-positive breast cancer who desires a long-acting reversible method.Copper intrauterine device
Answer
Match the VTE patient with heavy menses to the Levonorgestrel IUD; the active cervicitis patient to the Etonogestrel implant; the 37-year-old smoker to the Progestin-only pill; and the breast cancer patient to the Copper IUD.
Each match correctly identifies the WHO MEC Category 1 or 2 (safe) contraceptive option that aligns with the patient's specific request (e.g., long-acting, daily oral, management of heavy bleeding) while strictly avoiding Category 3 and 4 contraindications.
Step-by-Step Solution
Key Concept
Applying the WHO Medical Eligibility Criteria (MEC) to safely select contraceptive methods based on patient comorbidities.
Estimated Time:1m 30s